source
- STAT+: Big drugmakers tell House committee they will halt clinical trials at some hospitals in ChinaBig drugmakers tell U.S. House committee they will halt clinical trials at some hospitals in China.STAT · 1h ago↗ source
- Novartis CEO says AI could cut drug development time and boost success ratesAt an investor event in London, Novartis chief executive Vas Narasimhan, who also sits on the board of AI company Anthropic, explained how the Swiss drugmaker is turning to artificial intelligence…
- FDA approves treatments for four rare diseases; Pfizer inks $2.6 billion China licensing deal for CAR‑T therapy